Organisation: Regeneron Pharmaceuticals

Sign in

Organisation: Regeneron Pharmaceuticals

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

<p>For now, Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Zepbound are the leading therapies in a weight-loss market that could grow to $100bn (€92bn) by 2030, according to Goldman Sachs estimates.</p>

companies

Weight loss drugmakers race to make muscle retention treatments

Preserving muscle is an alluring goal for drugmakers that missed the first generation of obesity treatments and are seeking a foothold in the fast-growing and lucrative field

<p>Regeneron Pharmaceuticals was testing its experimental drug, odronextamab, in multiple late-stage trials in patients with follicular lymphoma.</p>

companies

Regeneron's blood cancer therapy faces setback as FDA raises trial concerns

Property Bridges attracts first tranche of peer-to-peer loans for Limerick housing project in record time

business

Property Bridges attracts first tranche of peer-to-peer loans for Limerick housing project in record time

Higher wages push stocks to records, but Dow misses 20,000 mark

business

Higher wages push stocks to records, but Dow misses 20,000 mark

Study finds cutting cholesterol to level of newborn babies reduces heart attack risk

world

Study finds cutting cholesterol to level of newborn babies reduces heart attack risk

Economic Recovery: 200 new jobs ‘another milestone’ for pharma industry

news

Economic Recovery: 200 new jobs ‘another milestone’ for pharma industry

Pharmaceutical company aiming to create 300 Limerick jobs

An American drug company is aiming to create 300 new jobs in Limerick as part of a proposed €217m investment.

Wed, 18 Dec, 2013